These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 23114744

  • 1. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Pimanov S, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V, Erglis A.
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [Abstract] [Full Text] [Related]

  • 2. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Sep; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 4. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V, Bektayeva R, Karabayeva R, Lebedev A, Akemeyeva K, Paloheimo L, Syrjänen K.
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [Abstract] [Full Text] [Related]

  • 7. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Aug; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 9. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE.
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [Abstract] [Full Text] [Related]

  • 10. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H, Lee JH, Lim J, Kim M, Kim Y, Han K, Kang CS, Shim SI, Kim JI, Park SH.
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [Abstract] [Full Text] [Related]

  • 11. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI, de Aretxabala U X, Santander D R, Sabah T S, Maira S J, Navarro R A, Planzer D M, Gómez L F, Etchart M, Gallegos I, Torrens X, Fasce P G, Reydet I.
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [Abstract] [Full Text] [Related]

  • 12. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M.
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [Abstract] [Full Text] [Related]

  • 13. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.
    Scand J Clin Lab Invest; 2005 Aug; 65(4):291-9. PubMed ID: 16076684
    [Abstract] [Full Text] [Related]

  • 14. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC, Kumar S, Krishnani N, Kumari N, Chourasia D, Tripathi S.
    Trop Gastroenterol; 2011 Aug; 32(4):292-8. PubMed ID: 22696910
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD, Lukyanchuk R, Sablin OA, Araslanova EI, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [Abstract] [Full Text] [Related]

  • 17. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K.
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [Abstract] [Full Text] [Related]

  • 18. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M.
    Int J Cancer; 2014 Mar 15; 134(6):1445-57. PubMed ID: 24009139
    [Abstract] [Full Text] [Related]

  • 19. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

  • 20. [Prevalence of Helicobacter pylori and gastritis in southern Germany. Results of a representative cross-sectional study].
    Haubrich T, Boeing H, Göres W, Hengels KJ, Scheuermann W, Wahrendorf J.
    Z Gastroenterol; 1993 Sep 15; 31(7-8):432-6. PubMed ID: 8379230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.